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Over the space of a few months virtually everything we know has been turned on its head. In Wuhan 
(China) during the closing months of 2019 a spillover event occurred in which the severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) was transferred from its animal host population 
into humans 1, 2. Spread mainly by respiratory droplets, the virus has a basic reproduction number 
(R0) of between 2-6 in an unprotected population making it more contagious than influenza, but 
considerably less so than measles. As SARS-CoV-2 rapidly spread across the planet, aided by our 
love of intercontinental travel, the local market outbreak of a mystery respiratory illness became a 
global pandemic of unimaginable proportions 3. Coronavirus disease 2019 (COVID-19), the illness 
that occurs in humans as a result of infection with SARS-CoV-2, has dominated the news for most 
of 2020 to date, and transformed the way in which we live, work, socialise, shop, exercise and 
communicate. In addition to this, it has placed intensive care medicine at the very centre of 
healthcare planning in the future, as the pandemic highlighted the weakness in our local, regional 
and national systems for dealing with crisis of this magnitude. The herculean efforts seen in 
intensive care units (ICUs) around the world is a testament to the dedication of those in our 
specialty and those who came to support us in our hour of need. However, for many of us, the 
situation was (and may still be) overwhelming and unsustainable; none of us would be eager to 
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return to it in a hurry. Once we have all taken a well-earned break, we need to brace ourselves for 
whatever lies ahead, equipped with the knowledge and experiences gained in during this pandemic.   
 
The disease  
Much has been written about COVID-19 in the last few months, both in medical and scientific 
journals and in the press. One of the many challenges for front line healthcare workers during the 
pandemic was wading through the abundance of daily literature updates and commentaries to try 
to distinguish fact from fiction. Inboxes were overwhelmed with hot-off-the-press articles, which 
ranged from case reports through to randomised controlled trials, alongside more leftfield 
hypotheses and ‘viral’ (using the internet rather than infections definition) emails. In non-pandemic 
times we would never dream of listening to the musings of a lone voice on something as important 
as the management of critically ill patients. However, during times of extreme pressure the desire 
for new information can overwhelm our usual caution with regard to new evidence, and encourage 
us to let our guard down and abandon the checks and measures that we would normally use to 
critically appraise it. Usually it takes years, if not decades, for us to carefully navigate a robust 
pathway from the discovery of a disease to the development of successful treatments for it. Those 
of us working in intensive care are sadly familiar with the years of failed searches for the ‘magic 
bullet’ to treat syndromes such as sepsis or acute respiratory distress syndrome (ARDS), so it would 
seem incredibly unlikely that we would stumble across one for this brand-new disease in a matter of 
mere months. We have grown to accept the fact that almost every large-scale multi-centre RCT of a 
new (or old) intervention conducted in intensive care leads to a frustratingly neutral finding. In the 
UK, the speed at which the research community turned its attention to tackling COVID-19 was 
extraordinary. The entire process of study approval was streamlined to allow crucial high priority 
studies to begin recruiting during the pandemic. Nationwide studies to capture data from COVID-19 
positive patients were immediately activated and as a result we now have some of the most 
comprehensive datasets in the world 4, 5. Early acquisition of data that is regularly updated is 
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arguably our most effective tool in the fight against an emerging disease. Francis Bacon’s iconic 
phrase from the end of the 16th century, “scientia potentia est” (knowledge is power), was one that 
resonated throughout the pandemic. As time progresses it will be interesting to see which of the 
potential treatments that were evaluated in early trials will emerge as effective and how these may 
specifically benefit critically ill patients.  
 
In a way that rarely occurs in modern medicine we also learnt a great deal about this disease from 
‘trial and error’. Back in March 2020 when the first cases started to be admitted to ICUs in the UK, 
we were convinced we knew what we were dealing with. We expected patients to arrive on ICU with 
ARDS in the guise of ‘single organ failure’ and geared up to manage it as we have learnt to over the 
last few decades 6. Whilst not entirely incorrect in our assumptions, we did need to modify our 
tactics a little to account for COID-19’s idiosyncrasies. In April 2020 the Intensive Care Society 
produced a synthesis of clinical experience from UK intensivists that summarised the state of play 
at that time 7. Key themes within the document were: the effectiveness of proning for severe 
hypoxaemia; the potential harm from excessive positive end-expiratory pressure (PEEP); the high 
incidence of iatrogenic renal failure from excessive diuresis; and the high rate of re-intubation. 
Releases like this provided support to clinicians who were likely to have made similar observations 
in their own ICU and facilitated large-scale adaptation to a rapidly developing landscape.  
 
The response 
I can vividly recall the first patient with COVID-19 being admitted to my own ICU. Despite being 
prepared for this eventuality, there was considerable apprehension amongst staff, with the 
realisation that the outbreak had begun. We had prepared our ICU to receive up to two patients, 
and if there was no longer any capacity within the NHS England Airborne High Consequence 
Infectious Diseases network, we would expand that to four 8. But this would be our absolute 
maximum. At the peak of the pandemic we were caring for more than 60 COVID-19 positive 
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critically ill patients at once, spread across three floors of the hospital, having commandeered the 
operating theatres, recovery areas and an outpatient treatment area. Each day, changes were 
occurring to the structure and processes of the hospital that would usually take several committees 
a number of years to even contemplate. In short, the response to this pandemic in hospitals 
throughout the National Health Service in the United Kingdom and around the world was nothing 
short of miraculous. As the admissions began to increase, units adapted within the boundaries of 
their walls, using side rooms to isolate infected individuals and then switching the model to 
cohorted bays of COVID-19 positive patients. Once full, ICUs expanded outwards, commonly using 
operating theatre complexes as an overflow area, as the necessary equipment and facilities to 
manage mechanically ventilated patients was already available there. In order to staff these 
expanded ICUs, we drafted in personnel from within and outside of our hospitals. Perhaps one of 
the most incredible local stories was a group of diver medical technicians volunteering to help on 
our ICU 9. Training had to occur for those unfamiliar with ICU to enable them to perform specific 
roles such as nursing support, proning patients, intravascular access, data collection, equipment 
management and the extremely sensitive and critical task of communicating with the families that, 
for the first time in our history, were not permitted to enter the hospital. The barrier we had to place 
between patients and their loved ones was necessary to protect healthcare workers and the public 
but created unthinkable scenarios, particularly at the end of life. Teams worked around the clock to 
communicate to families and use video technology to bridge this emotional gulf. Staff rose to the 
challenges and many grew into new roles. Our ICU family expanded beyond our wildest dreams; 
shift handovers became a hospital-wide event where staff from all manner of backgrounds would 
congregate in a safe manner to keep ICU running effectively. Support arrived in abundance from 
outside the hospital, in the form of food, clothing, accommodation, essential supplies and all sorts 
of treats. Everyone wanted to play their part in the greatest challenge ever faced by the modern 




Every story comes to an end and, at the time of writing, the peak of the pandemic in the United 
Kingdom appears to have passed and normality is slowly beginning to return. De-escalation is as 
logistically perplexing as escalation and hospitals have had to make decisions on when and how 
their huge ICU teams should begin to stand down to allow a shrinkage of their floorspace, back to 
their original setup. As the number of admissions through emergency departments began to 
plateau, then fall, the pressure on wards and ICUs stabilised. In London we are now in a state of 
steady decline in terms of number of inpatients and an there is a growing eagerness to resume 
services such as elective surgery. The de-escalation has been deliberately cautious in many centres 
due to the underlying fear of a ‘second wave’ as was seen in the influenza pandemic of 1918 10. 
Whilst in 1918 the second wave was unlikely have been due to any premature easing of social 
isolation, there is good reason to believe that if we were all to abandon the practices we have all 
become so familiar with (quarantine, isolation, shielding, social distancing, the wearing of masks 
and the washing of hands) a second wave may have already begun by the time this article is 
published. So, whilst we may want to celebrate and get back to whatever we were doing before the 
pandemic, it is important to remember that “it ain't over 'til it's over.” The problem is, how do we 
know when it is over? How long do we wait until we can be sure that COVID-19 is gone for good? 
Can we ever be sure of that? Do we need to remain on guard until a vaccination programme is 
established? So many vital questions that no one can yet answer with any authority.  
 
The future 
We should not believe the media’s myth that pandemics are a 100 year phenomenon. The 
frequency of pandemics has been increasing over the last few decades, particularly due to strains of 
influenza (H2N2 (‘Asian flu’) in 1957-58, H3N2 in 1968, and H1N1 (‘swine flu’) in 2009-10), and is 
likely to continue doing so because of the intermingling of human civilisation and environments 
close to animal hosts of disease 11. As healthcare workers responsible for the survival of critically ill 
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patients we need to ensure we are ready for the next pandemic, and the one that follows it. Many 
useful articles are now appearing in the literature to help us think this through in a much calmer way 
than we were perhaps capable of in the heat of the moment during our first pandemic 12. Crucial to 
our future response will be linking local ICUs to provide a more streamlined service to the 
population, and developing a common language and approach to aid escalation as a pandemic 
develops. The CRITCON framework is an excellent example of this, outlining an escalation plan and 
operational matrix for hospitals to follow during a developing pandemic 13. Strategic planning is also 
necessary to minimise the impact of future pandemic surges to the delivery of other essential 
medical services. Particular attention should be devoted to mitigating the secondary harm from the 
reduction in urgent elective surgery (particularly for cancer) during the surge 14. Whilst we cannot be 
experts in every facet of pandemic medicine, most of us have gained a vast amount of hard-won 
experience in this first phase, and must find ourselves in far better place than at the beginning of 
2020 with regards to preparedness for what may lie ahead of us.  
 
Conclusion 
Thank you to everyone who played a role in what has likely been the largest ever global healthcare 
response to an infectious disease. As a specialty, we have demonstrated adaptability to a rapidly 
developing novel disease and global catastrophe, and shone a light on the absolute necessity of 
intensive care medicine in a modern healthcare system. 
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